Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghai Conant Optical CoHKSE:02276 -5.46%78 ROA % is 16.85% as of Dec. 2025, which is 37% above its 10-year median of 12.31. GuruFocus rates HKSE:02276 with a GF Score™ of 78/100 and a GF Value™ of HK$15.68 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Shanghai Conant Optical Co ranks better than 96.37% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Shanghai Conant Optical Co's annualizedNet Income for the quarter that ended in Dec. 2025 was HK$629 Mil.
Shanghai Conant Optical Co's average Total Assets over the quarter that ended in Dec. 2025 was HK$3,735 Mil. Therefore, Shanghai Conant Optical Co's annualized ROA % for the quarter that ended in Dec. 2025 was 16.85%.
The historical rank and industry rank for Shanghai Conant Optical Co's ROA % or its related term are showing as below:
HKSE:02276'
s ROA % Range Over the Past 10 Years
Min: 7.25 Med: 12.31 Max: 19.37
Current: 14.89
During the past 8 years, Shanghai Conant Optical Co's highest ROA % was 19.37%. The lowest was 7.25%. And the median was 12.31%.
HKSE:02276's ROA % is ranked better than 96.37% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 0.73
vs HKSE:02276: 14.89
Shanghai Conant Optical Co (HKSE:02276) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Shanghai Conant Optical Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Conant Optical Co ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shanghai Conant Optical Co's ROA % distribution charts can be found below:
* The bar in red indicates where Shanghai Conant Optical Co's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
ROA % is displayed in the 30-year financial page.
Shanghai Conant Optical Co (HKSE:02276) has a ROA % of 16.85% as of Dec. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Shanghai Conant Optical Co and its competitors. This is 37% above median its historical median of 12.31. Over the past decade, Shanghai Conant Optical Co's ROA % has ranged from 7.25 to 19.37. According to the industry distribution chart, Shanghai Conant Optical Co ranks #31 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 3.6%.
Is Shanghai Conant Optical Co's ROA % too high?
Shanghai Conant Optical Co's current ROA % of 16.85% is 37% above median its 10-year median of 12.31. Over the past 10 years, this metric has ranged from a low of 7.25 to a high of 19.37. The Medical Devices & Instruments industry median ROA % is 0.73. Shanghai Conant Optical Co's value of 16.85% is 2208.2% above this industry median. Based on the distribution chart, Shanghai Conant Optical Co ranks #31 out of 853 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai Conant Optical Co has a GF Score™ of 78/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Conant Optical Co's ROA % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shanghai Conant Optical Co ranks #31 out of 853 companies for ROA %. This places Shanghai Conant Optical Co in the top 4% of its industry — outperforming the majority of peers. The industry median ROA % is 0.73. Shanghai Conant Optical Co's value of 16.85% is 2208.2% above this benchmark. Historically, Shanghai Conant Optical Co's own ROA % has ranged from 7.25 to 19.37 over the past decade. While the company's 10-year median is 12.31 vs. the industry median of 0.73, Shanghai Conant Optical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.73, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Conant Optical Co's current ROA % of 16.85% is 2208.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Shanghai Conant Optical Co and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Conant Optical Co's current ROA % is 16.85%, which is 37% above median its own 10-year median of 12.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Conant Optical Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Conant Optical Co (HKSE:02276) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$15.68, compared to a current price of HK$38.44 — trading 145.2% above its estimated fair value. The current ROA % is 16.85%, which is 37% above median its 10-year median of 12.31 and 2208.2% above the Medical Devices & Instruments industry median of 0.73. Shanghai Conant Optical Co's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Shanghai Conant Optical Co (HKSE:02276), the current ROA % is 16.85% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Conant Optical Co (HKSE:02276) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Conant Optical Co stock appears to be overvalued.
The current stock price of HK$38.44 is trading 145.2% above its estimated GF Value™ of HK$15.68.
GuruFocus considers Shanghai Conant Optical Co to be Significantly Overvalued.
Key valuation signals for HKSE:02276:
ROA %: 16.85% (37% above median its 10-year median of 12.31)
GF Value™: HK$15.68 vs. price of HK$38.44 (145.2% above fair value)
Industry Position: 2208.2% above the Medical Devices & Instruments median (#31 of 853)
No single metric tells the full story. See the HKSE:02276 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AddressNo. 1-42, Lane 83, Hongxiang North Road, 4th Floor, Building 35, Lin-gang Special Area, China (Shanghai) Pilot Free Trade Zone China, Shanghai, CHN
Shanghai Conant Optical Co Ltd is a resin spectacle lens manufacturer in China. The company offers a wide range of resin spectacle lenses to its customers including standardized lenses and customized lenses. The spectacle lenses are also tinted, coated, or cast with various films or coatings for added functionality, such as polarised, photochromic, blue-ray blocking, anti-scratch, anti-reflection, and anti-smudge. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the Americas, Europe, Oceania, Africa, and Asia (except for mainland China). It products include: CR-Freeform; CoMax; AC lens; Gaming Glassed, Antifog Lens; MyoEase; Polycarbonate lens; Photochromic coating lens; SingleVision Finished Lens; and Others.
78GF Score
Get the complete analysis for HKSE:02276
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02276 has been successfully added to your 
